drugset / Trial / NCT02489435

Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers

NCT02489435

Phase 1 Completed 36 enrolled Viriom
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study to assess safety and tolerability of VM-1500 and to determine main pharmacokinetic parameters of VM-1500 after multiple oral administration in adult healthy subjects.

Timeline

Start
2012-07
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Elsulfavirine Small molecule 10 mg Oral
Subject Elsulfavirine Small molecule 20 mg Oral
Subject Elsulfavirine Small molecule 30 mg Oral